Clinical Trial Update: Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects [Phase 3]

View source ↗

Summary

Phase 3 crossover trial comparing the New Mark VII pen with the Genotropin Pen for growth hormone deficiency in children and adults. The study assessed convenie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Genotropin Pen (somatropin)
• New Mark VII (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2012-05-14